nav-left cat-right
cat-right

BioFocus to Offer IMD’s Natural Product Libraries ...

BioFocus and InterMed Discovery (IMD) inked a marketing collaboration that will allow BioFocus to offer IMD’s natural product screening libraries through its drug discovery services. IMD will in addition provide follow-on services to BioFocus. “We have been impressed with the scale of IMD’s natural product discovery capabilities, and we believe that when InterMed’s natural product libraries and services are...

Optimer Pharmaceuticals Receives Milestone Payment...

SAN DIEGO, July 8 /PRNewswire-FirstCall/ — Optimer Pharmaceuticals, Inc. today announced it has received a $500,000 milestone payment from Cempra Pharmaceuticals, Inc. pursuant to the terms of a licensing agreement between the companies.  The milestone payment was made as a result of Cempra’s continuing development of a next-generation macrolide (CEM-101) for the treatment of respiratory infections. Cempra...

CLC bio’s enterprise platform wins award at Bio-...

Press Release from CLC bioBoston, Massachusetts, USA — April 30, 2009 — CLC bio’s enterprise platform for Next Generation Sequencing data analysis, CLC Genomics Server, has just been awarded the “Best of Show” prize at the Bio-IT World Conference & Expo 2009 – an award judged by a team of Bio-IT World magazine editors and leading industry experts. Bio-IT World Editor-in-Chief...

A new approach to functional screening of siRNA kn...

KINGSTON, England, Nov. 25, 2008-Guava Technologies, Inc. presented at the recent Molecular Targets & Cancer Therapeutics Symposium* information on their recent advancements that describe an experimental methodology and the new Guava® Simplicity Analysis Software which exploit the advantages of plate based flow technology. These technological improvements result in an overall process that can significantly...

Virtual Screening Gives Drug Design a Boost

San Diego, CA (OBBeC) – Researchers at the University of California, San Diego, developed a unique computational approach to identify key compounds that could lead to new drugs to combat African sleeping sickness — a disease spread by the biting tsetse fly and caused by the parasite Trypanosoma brucei. Around 150,000 people per year get African sleeping sickness. Unless treated, the illness is invariably fatal...

Otava develops virtual screening system

Mathematical modelling in biology is often a problem with interactions estimation between a biomolecular target and small molecule compounds. Knowledge of this interaction allows the interruption of certain processes in cells, for example it can impede diseases such as cancer. This is why so many efforts focus on designing better models and algorithms for high-throughput virtual screening techniques. Otava began developing...
Page 5 of 9« First...34567...Last »